Q1 2025 Chemical Industry: Diverging Trends

The first quarter of 2025 highlights a continued divergence between the European and US chemical industries.

two trend lines
© Adobe Stock

The first quarter of 2025 highlights a continued divergence between the European and US chemical industries. According to CEFIC, the European sector remains mired in uncertainty, with output growth forecast at just 0.5% for the year—down sharply from 2.5% in 2024—amid persistently weak demand, high energy costs, and capacity utilization well below historical averages. Notably, Belgium saw a 9.1% production increase, but major economies such as the Netherlands and France posted declines, and Europe’s chemicals trade surplus shrank by 25% year-on-year as imports, especially from China, outpaced domestic output.

In contrast, the American Chemistry Council’s (ACC) Q1 2025 Economic Sentiment Index signals a more stable environment for US chemical manufacturers. While not immune to global headwinds, the US industry benefits from comparatively lower energy costs and steadier domestic demand, helping maintain higher capacity utilization rates and a more optimistic outlook for the remainder of the year.

For a deeper dive into these regional trends, visit our website and consult the full CEFIC Q1 Chemical Trends Report and the ACC’s Economic Sentiment Index for Q1 2025.


Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 24-25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Special Issue

Circular Plastics Economy
Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

most read

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.